Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia J M Best

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
JACC. Cardiovascular Interventions|September 24, 2011
Percutaneous coronary revascularization for myocardial infarction in chronic kidney disease: recognizing the risk while seizing the benefitsPatricia J M Best
Women'S Health (London, England)|December 17, 2008
Cardiovascular disease in older women: a challenge in diagnosis and treatmentRekha Mankad, Patricia J M Best
Sexuality, Reproduction & Menopause|September 13, 2011
Implications for reproductive medicine: Sex differences in cardiovascular diseaseVirginia M Miller, Patricia J M Best
JACC. Cardiovascular Interventions|May 26, 2009
Does kidney function alter the benefit of reperfusion therapy for ST-segment elevation myocardial infarction?Peter B Berger, Patricia J M Best
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 6, 2004
Can percutaneous coronary interventions reduce death and myocardial infarction in stable and unstable coronary disease?Patricia J M Best, Peter B Berger
American Heart Journal|March 28, 2003
Chronic kidney disease as a cardiovascular risk factorPatricia J M Best, David R Holmes
Journal of Cardiothoracic and Vascular Anesthesia|April 17, 2003
Pro: standard percutaneous coronary intervention is the procedure of choice for myocardial revascularizationPatricia J M Best, Peter B Berger
Current Treatment Options in Cardiovascular Medicine|December 27, 2011
Prevention and management of contrast-induced acute kidney injuryPatricia J M Best, David R Holmes
JACC. Cardiovascular Interventions|September 21, 2010
Intracoronary glycoprotein IIb/IIIa inhibitors from questioning the logic to weighing the dataPeter B Berger, Patricia J M Best
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2017
OxPL: Elusive Risk Factor in Calcific Aortic Valve Disease or Another Piece of the Puzzle?Patricia J M Best, Nalini M Rajamannan
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
JACC. Cardiovascular Interventions|September 24, 2011
Percutaneous coronary revascularization for myocardial infarction in chronic kidney disease: recognizing the risk while seizing the benefitsPatricia J M Best
Women'S Health (London, England)|December 17, 2008
Cardiovascular disease in older women: a challenge in diagnosis and treatmentRekha Mankad, Patricia J M Best
Sexuality, Reproduction & Menopause|September 13, 2011
Implications for reproductive medicine: Sex differences in cardiovascular diseaseVirginia M Miller, Patricia J M Best
JACC. Cardiovascular Interventions|May 26, 2009
Does kidney function alter the benefit of reperfusion therapy for ST-segment elevation myocardial infarction?Peter B Berger, Patricia J M Best
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 6, 2004
Can percutaneous coronary interventions reduce death and myocardial infarction in stable and unstable coronary disease?Patricia J M Best, Peter B Berger
American Heart Journal|March 28, 2003
Chronic kidney disease as a cardiovascular risk factorPatricia J M Best, David R Holmes
Journal of Cardiothoracic and Vascular Anesthesia|April 17, 2003
Pro: standard percutaneous coronary intervention is the procedure of choice for myocardial revascularizationPatricia J M Best, Peter B Berger
Current Treatment Options in Cardiovascular Medicine|December 27, 2011
Prevention and management of contrast-induced acute kidney injuryPatricia J M Best, David R Holmes
JACC. Cardiovascular Interventions|September 21, 2010
Intracoronary glycoprotein IIb/IIIa inhibitors from questioning the logic to weighing the dataPeter B Berger, Patricia J M Best
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2017
OxPL: Elusive Risk Factor in Calcific Aortic Valve Disease or Another Piece of the Puzzle?Patricia J M Best, Nalini M Rajamannan
Pageof 7